English

CHINA POLYPEPTIDE GROUP, INC.

EDGAR

CHPN Quarterly report (10-Q) · filed 2011-08-22

12 filing records in this dataset, filed from 2008-12-22 to 2011-08-22. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.07 million USD

2011 Q3 · USD

Exact inputs and evidence

Revenue: 1072892 USD Source

Operating margin

-552.96%

2011 Q3 · %

Exact inputs and evidence

Operating Income: -5932693 USD Source
Revenue: 1072892 USD Source

Operating cash flow

-3.3 million USD

2011 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -111005 USD Source
Operating Cash Flow: 3187719 USD Source

Cash and cash equivalents: 14.6 million USD 2011-06-30 Source
Exact value

14562808 USD
Long-term debt including current maturities: Not available
Shares outstanding: 11.9 million shares 2011-06-30 Source
Exact value

11939967 shares

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2011-08-22.

Financial data available through: 2010-09-30.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2010-09-30
Operating income: 2 of 11 periods available· newest 2010-09-30
Net income: 2 of 11 periods available· newest 2010-09-30
Operating cash flow: 2 of 11 periods available· newest 2010-09-30
Capital expenditure: 2 of 11 periods available· newest 2010-09-30
Total assets: 2 of 11 periods available· newest 2010-09-30
liabilities: No compatible figures in this window
Current assets: 2 of 11 periods available· newest 2010-09-30
Current liabilities: 2 of 11 periods available· newest 2010-09-30
Cash and cash equivalents: 2 of 11 periods available· newest 2010-09-30
long term debt: No compatible figures in this window
Shares outstanding: 1 of 11 periods available· newest 2010-09-30

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+0.9%

Prior period

USD 37.72 million

2008-10-01 – 2009-09-30
Current period

USD 38.06 million

2009-10-01 – 2010-09-30

Exact inputs and evidence

38061827 − 37724869 = 336958 USD

37724869 USD · 2008-10-01 – 2009-09-30
Inspect prior input Prior source
38061827 USD · 2009-10-01 – 2010-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CHINA POLYPEPTIDE GROUP, INC. · 2010-09-30 CHINA POLYPEPTIDE GROUP, INC. (edgar:1435530) Year-over-year change in Revenue: 336958 USD Concept: fundies:Revenue Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1435530?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 38061827 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1435530/0001144204-11-002081.txt#10857 Input fundies:Revenue: 37724869 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1435530/0001144204-11-002081.txt#10857
The citation records this snapshot. The page link may show a newer release later.
Net income
-47.8%

Prior period

USD 10.52 million

2008-10-01 – 2009-09-30
Current period

USD 5.49 million

2009-10-01 – 2010-09-30

Exact inputs and evidence

5491392 − 10522067 = -5030675 USD

10522067 USD · 2008-10-01 – 2009-09-30
Inspect prior input Prior source
5491392 USD · 2009-10-01 – 2010-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CHINA POLYPEPTIDE GROUP, INC. · 2010-09-30 CHINA POLYPEPTIDE GROUP, INC. (edgar:1435530) Year-over-year change in Net income: -5030675 USD Concept: fundies:NetIncome Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1435530?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 5491392 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1435530/0001144204-11-002081.txt#12767 Input fundies:NetIncome: 10522067 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1435530/0001144204-11-002081.txt#12767
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 10.26 million

Prior period

−USD 125,880

2008-10-01 – 2009-09-30
Current period

USD 10.14 million

2009-10-01 – 2010-09-30

Exact inputs and evidence

10135790 − -125880 = 10261670 USD

-125880 USD · 2008-10-01 – 2009-09-30
Inspect prior input Prior source
10135790 USD · 2009-10-01 – 2010-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CHINA POLYPEPTIDE GROUP, INC. · 2010-09-30 CHINA POLYPEPTIDE GROUP, INC. (edgar:1435530) Year-over-year change in Operating cash flow: 10261670 USD Concept: fundies:OperatingCashFlow Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1435530?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 10135790 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1435530/0001144204-11-002081.txt#13047 Input fundies:OperatingCashFlow: -125880 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1435530/0001144204-11-002081.txt#13047
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+5,640.9%

Prior period

USD 70,818

2008-10-01 – 2009-09-30
Current period

USD 4.07 million

2009-10-01 – 2010-09-30

Exact inputs and evidence

4065603 − 70818 = 3994785 USD

70818 USD · 2008-10-01 – 2009-09-30
Inspect prior input Prior source
4065603 USD · 2009-10-01 – 2010-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CHINA POLYPEPTIDE GROUP, INC. · 2010-09-30 CHINA POLYPEPTIDE GROUP, INC. (edgar:1435530) Year-over-year change in Capital expenditure: 3994785 USD Concept: fundies:CapitalExpenditure Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1435530?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 4065603 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1435530/0001144204-11-002081.txt#13087 Input fundies:CapitalExpenditure: 70818 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1435530/0001144204-11-002081.txt#13087
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2009-10-01 – 2010-09-30

Revenue USD 38.06 million 100% of revenue
Operating costs Derived USD 30.3 million 80% of revenue
Operating income USD 7.76 million 20% of revenue
Tax, interest and other Derived USD 2.27 million 6% of revenue
Net income USD 5.49 million 14% of revenue

Cash

Operating cash flow USD 10.14 million 27% of revenue
Capital expenditure USD 4.07 million 11% of revenue
Free cash flow Derived USD 6.07 million 16% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2009 28%67%
2010 14%80%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2009 2008-10-01 – 2009-09-30	37724869	25089607 Derived	12635262	2113195 Derived	10522067	-196698 Derived	Source 2008-10-01 – 2009-09-30: 37724869 USD Inspect Revenue Open source 2008-10-01 – 2009-09-30: 12635262 USD Inspect Operating Income Open source 2008-10-01 – 2009-09-30: 10522067 USD Inspect Net Income Open source 2008-10-01 – 2009-09-30: -125880 USD Inspect Operating Cash Flow Open source 2008-10-01 – 2009-09-30: 70818 USD Inspect Capital Expenditure Open source
2010 2009-10-01 – 2010-09-30	38061827	30298221 Derived	7763606	2272214 Derived	5491392	6070187 Derived	Source 2009-10-01 – 2010-09-30: 38061827 USD Inspect Revenue Open source 2009-10-01 – 2010-09-30: 7763606 USD Inspect Operating Income Open source 2009-10-01 – 2010-09-30: 5491392 USD Inspect Net Income Open source 2009-10-01 – 2010-09-30: 10135790 USD Inspect Operating Cash Flow Open source 2009-10-01 – 2010-09-30: 4065603 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 38.1M 2010

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-09-30	Revenue	37724869	Revenue: 37724869 Open source
20102010-09-30	Revenue	38061827	Revenue: 38061827 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

0.9% 2010

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20092009-09-30	Year over year	No prior comparable period	Revenue: 37724869 Open source
20102010-09-30	Year over year	0.9%	Revenue: 38061827 Open source Revenue: 37724869 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 20.4% 2010

Net margin 14.4% 2010

Free cash flow margin 15.9% 2010

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20092009-09-30	Operating margin	33.5%	Operating Income: 12635262 Open source Revenue: 37724869 Open source
20102010-09-30	Operating margin	20.4%	Operating Income: 7763606 Open source Revenue: 38061827 Open source
20092009-09-30	Net margin	27.9%	Net Income: 10522067 Open source Revenue: 37724869 Open source
20102010-09-30	Net margin	14.4%	Net Income: 5491392 Open source Revenue: 38061827 Open source
20092009-09-30	Free cash flow margin	-0.5%	Revenue: 37724869 Open source Operating Cash Flow: -125880 Open source Capital Expenditure: 70818 Open source
20102010-09-30	Free cash flow margin	15.9%	Revenue: 38061827 Open source Operating Cash Flow: 10135790 Open source Capital Expenditure: 4065603 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 10.1M 2010

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-09-30	Operating cash flow	-125880	Operating Cash Flow: -125880 Open source
20102010-09-30	Operating cash flow	10135790	Operating Cash Flow: 10135790 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 6.1M 2010

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-09-30	Free cash flow	-196698	Operating Cash Flow: -125880 Open source Capital Expenditure: 70818 Open source
20102010-09-30	Free cash flow	6070187	Operating Cash Flow: 10135790 Open source Capital Expenditure: 4065603 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2009-09-30	Liabilities / assets	Not reported	Total Assets: 39664793 Open source
2010-09-30	Liabilities / assets	Not reported	Total Assets: 50726988 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.18× 2010

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20092009-09-30	Current assets / current liabilities	1.5×	Current Assets: 31632222 Open source Current Liabilities: 21019501 Open source
20102010-09-30	Current assets / current liabilities	3.18×	Current Assets: 32757533 Open source Current Liabilities: 10285184 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2009 2008-10-01 – 2009-09-30	USD 10.52 million Exact value Exact value: 10522067 USD 2008-10-01 – 2009-09-30: 10522067 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA POLYPEPTIDE GROUP, INC. · 2009-09-30 CHINA POLYPEPTIDE GROUP, INC. (edgar:1435530) Net Income: 10522067 USD Concept: fundies:NetIncome Period: 2008-10-01 to 2009-09-30 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1435530/explain?concept=fundies%3ANetIncome&period=2009-09-30&surface=latest&period_type=duration&start=2008-10-01&unit=USD&dimensions= Input fundies:NetIncome: 10522067 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1435530/0001144204-11-002081.txt#12767 The citation records this snapshot. The page link may show a newer release later.	−USD 125,880 Exact value Exact value: -125880 USD 2008-10-01 – 2009-09-30: -125880 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHINA POLYPEPTIDE GROUP, INC. · 2009-09-30 CHINA POLYPEPTIDE GROUP, INC. (edgar:1435530) Operating Cash Flow: -125880 USD Concept: fundies:OperatingCashFlow Period: 2008-10-01 to 2009-09-30 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1435530/explain?concept=fundies%3AOperatingCashFlow&period=2009-09-30&surface=latest&period_type=duration&start=2008-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -125880 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1435530/0001144204-11-002081.txt#13047 The citation records this snapshot. The page link may show a newer release later.	USD 70,818 Exact value Exact value: 70818 USD 2008-10-01 – 2009-09-30: 70818 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHINA POLYPEPTIDE GROUP, INC. · 2009-09-30 CHINA POLYPEPTIDE GROUP, INC. (edgar:1435530) Capital Expenditure: 70818 USD Concept: fundies:CapitalExpenditure Period: 2008-10-01 to 2009-09-30 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1435530/explain?concept=fundies%3ACapitalExpenditure&period=2009-09-30&surface=latest&period_type=duration&start=2008-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 70818 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1435530/0001144204-11-002081.txt#13087 The citation records this snapshot. The page link may show a newer release later.	−USD 196,698 Calculation and evidence -125880 − 70818 USD Exact free cash flow: -196698 USD 2008-10-01 – 2009-09-30: -125880 USD · Inspect Operating Cash Flow · Source 2008-10-01 – 2009-09-30: 70818 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHINA POLYPEPTIDE GROUP, INC. · 2009-09-30 CHINA POLYPEPTIDE GROUP, INC. (edgar:1435530) Free cash flow: -196698 USD Concept: free-cash-flow Period: 2008-10-01 to 2009-09-30 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1435530?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -125880 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1435530/0001144204-11-002081.txt#13047 Input fundies:CapitalExpenditure: 70818 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1435530/0001144204-11-002081.txt#13087 The citation records this snapshot. The page link may show a newer release later.
2010 2009-10-01 – 2010-09-30	USD 5.49 million Exact value Exact value: 5491392 USD 2009-10-01 – 2010-09-30: 5491392 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA POLYPEPTIDE GROUP, INC. · 2010-09-30 CHINA POLYPEPTIDE GROUP, INC. (edgar:1435530) Net Income: 5491392 USD Concept: fundies:NetIncome Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1435530/explain?concept=fundies%3ANetIncome&period=2010-09-30&surface=latest&period_type=duration&start=2009-10-01&unit=USD&dimensions= Input fundies:NetIncome: 5491392 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1435530/0001144204-11-002081.txt#12767 The citation records this snapshot. The page link may show a newer release later.	USD 10.14 million Exact value Exact value: 10135790 USD 2009-10-01 – 2010-09-30: 10135790 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHINA POLYPEPTIDE GROUP, INC. · 2010-09-30 CHINA POLYPEPTIDE GROUP, INC. (edgar:1435530) Operating Cash Flow: 10135790 USD Concept: fundies:OperatingCashFlow Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1435530/explain?concept=fundies%3AOperatingCashFlow&period=2010-09-30&surface=latest&period_type=duration&start=2009-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 10135790 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1435530/0001144204-11-002081.txt#13047 The citation records this snapshot. The page link may show a newer release later.	USD 4.07 million Exact value Exact value: 4065603 USD 2009-10-01 – 2010-09-30: 4065603 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHINA POLYPEPTIDE GROUP, INC. · 2010-09-30 CHINA POLYPEPTIDE GROUP, INC. (edgar:1435530) Capital Expenditure: 4065603 USD Concept: fundies:CapitalExpenditure Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1435530/explain?concept=fundies%3ACapitalExpenditure&period=2010-09-30&surface=latest&period_type=duration&start=2009-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4065603 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1435530/0001144204-11-002081.txt#13087 The citation records this snapshot. The page link may show a newer release later.	USD 6.07 million Calculation and evidence 10135790 − 4065603 USD Exact free cash flow: 6070187 USD 2009-10-01 – 2010-09-30: 10135790 USD · Inspect Operating Cash Flow · Source 2009-10-01 – 2010-09-30: 4065603 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHINA POLYPEPTIDE GROUP, INC. · 2010-09-30 CHINA POLYPEPTIDE GROUP, INC. (edgar:1435530) Free cash flow: 6070187 USD Concept: free-cash-flow Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1435530?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 10135790 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1435530/0001144204-11-002081.txt#13047 Input fundies:CapitalExpenditure: 4065603 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1435530/0001144204-11-002081.txt#13087 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

12 filings · 137 latest values · 137 originally reported values

Dataset published 2026-11-07. Source filing dates and reporting periods are shown separately.

Identifiers: 0001435530, 1435530, CHPN, edgar:1435530

Also known as CHINA POLYPEPTIDE GROUP, INC., China Polypeptide Group, Inc., Hamptons Extreme, Inc.

CHINA POLYPEPTIDE GROUP, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2010 2009-10-01 – 2010-09-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation